Thirty Madison Raises $140M in Series C

Thirty Madison has successfully raised $140M in a Series C at a $1B valuation led by Mousse Partners, Johnson & Johnson Innovation.

Company Overview

Thirty Madison is a HealthTech company headquartered in New York, NY, founded in 2016 with 400+ employees.

Multi-specialty telehealth platform

Fundraising Details

Amount Raised: $140M
Round Type: Series C
Valuation: $1B
Date: 2021-05-18
Investors: Mousse Partners, Johnson & Johnson Innovation

About Thirty Madison

Multi-specialty telehealth platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: New York, NY
Founded: 2016
Team Size: 400+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Thirty Madison's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Thirty Madison's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1B valuation marks an important milestone for Thirty Madison, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Thirty Madison is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2021-05-18. For more information about Thirty Madison, visit their headquarters at New York, NY.

Thirty Madison